Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Link opens in a new tab
Search content at Penn State
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Pseudobulbar affect: Prevalence and management
Aiesha Ahmed
,
Zachary Simmons
Department of Neurology
Department of Medicine
Division of General Internal Medicine
Penn State Neuroscience Institute
Division of Neuromuscular Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
87
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pseudobulbar affect: Prevalence and management'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Neuroscience
Selective Serotonin Reuptake Inhibitor
100%
Alzheimer's Disease
100%
Glutamic Acid
100%
Neurotrauma
100%
Traumatic Brain Injury
100%
Mood Disorder
100%
Bipolar Disorder
100%
Antidepressant
100%
Nervous System Disorder
100%
Serotonin
100%
Amyotrophic Lateral Sclerosis
100%
Tricyclic Antidepressant
100%
Social Interaction
100%
Multiple Sclerosis
100%
Disinhibition
100%
Dextromethorphan Plus Quinidine
100%
Comorbidity
100%
Cerebrovascular Accident
100%
Intracranial Tumor
100%
Side Effect
100%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Prevalence
100%
Glutamic Acid
100%
Syndrome
100%
Tricyclic Antidepressant
100%
Antidepressant
100%
Serotonin
100%
Amyotrophic Lateral Sclerosis
100%
Bipolar Disorder
100%
Mood Disorder
100%
Multiple Sclerosis
100%
Neurologic Disease
100%
Traumatic Brain Injury
100%
Selective Serotonin Reuptake Inhibitor
100%
Cerebrovascular Accident
100%
Intracranial Tumor
100%
Comorbidity
100%
Side Effect
100%
Keyphrases
Pseudobulbar Affect
100%
Alzheimer's Disease
20%
Glutamate
20%
Effective Treatment
20%
Traumatic Brain Injury
20%
Treatment Options
20%
Proper Management
20%
Accurate Identification
20%
Bipolar Disorder
20%
Mood Disorders
20%
Elderly Patients
20%
Multiple Sclerosis
20%
Antidepressants
20%
Social Interaction
20%
Serotonin
20%
Disinhibition
20%
Proper Treatment
20%
Neurological Diseases
20%
Side Effect Profile
20%
Amyotrophic Lateral Sclerosis
20%
Tricyclic Antidepressants
20%
Selective Serotonin Reuptake Inhibitors
20%
Psychological Consequences
20%
Brain Tumor
20%
Misidentified
20%
Multiple Comorbidities
20%
Concomitant Medications
20%
Scale Validation
20%
Cerebellar Degeneration
20%
Alzheime's Disease
20%
Medicine and Dentistry
Prevalence
100%
Pseudobulbar Affect
100%
Selective Serotonin Reuptake Inhibitor
20%
Clinician
20%
Contraindication
20%
Elderly Patient
20%
Alzheimer's Disease
20%
Neurologic Disease
20%
Glutamic Acid
20%
Apoplexy
20%
Tricyclic Antidepressant
20%
Serotonin
20%
Traumatic Brain Injury
20%
Bipolar Disorder
20%
Multiple Sclerosis
20%
Amyotrophic Lateral Sclerosis
20%
Mood Disorder
20%
Social Interaction
20%
Comorbidity
20%
Intracranial Tumor
20%
Antidepressant
20%
Treatment Option
20%
Side Effect
20%
Effective Treatment
20%